You searched for Cybin - Page 55 of 60

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Leverages Key Experience, Prepares Entry into Psychedelic Mushroom Market

Pure Extracts (CSE: PULL), a plant-based extraction company, is focused on cannabis, hemp, and functional mushroom sectors, the last of which is projected to rise to a value of $34.4 billion by the end of 2024. Seeking to capitalize on the growing interest within the sector, Pure Extracts has expanded its business model to include … Continue reading “QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Leverages Key Experience, Prepares Entry into Psychedelic Mushroom Market”

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces New CFO, General Counsel

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) chairman and CEO Roger McIntyre today announced the company’s appointment of Stephen R. Brooks as its new chief financial officer and Peter Rizakos as the firm’s new general counsel. According to the update, these appointments complete the company’s new top management team put into place by Dr. McIntyre … Continue reading “QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces New CFO, General Counsel”

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Article Outlining Future Potential in Novel Agents for Bipolar Disorders

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) today announced the publication of an article led by Dr. Roger McIntyre, CEO of Champignon Brands Inc. The article, “Bipolar Disorders” is published in The Lancet – one of the world’s best-known and most reputable scientific journals in medicine. According to the update, the article contributes to The … Continue reading “QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Article Outlining Future Potential in Novel Agents for Bipolar Disorders”

Pure Extracts Technologies (CSE: PULL) Draws Out Expansion Plans in Anticipation of Regulatory Changes Within Mushroom Sector

Pure Extracts Technologies Corp. has announced plans to expand, build fourth unit in dedicated towards research, development of psilocybin Announcement on its expansion plans come shortly after the Company revealed it plans to apply to Health Canada for a Dealer’s License Award of Dealer’s License would allow Pure Extracts to cultivate, harvest and procure controlled … Continue reading “Pure Extracts Technologies (CSE: PULL) Draws Out Expansion Plans in Anticipation of Regulatory Changes Within Mushroom Sector”

Pure Extracts Technologies (CSE: PULL) Signs LOI with PURICA(TM) to Further Research into Mushrooms Wellness Products

Pure Extracts Technologies revealed it had recently retained global consultancy to advise on application for Dealer’s License under Health Canada If granted, license would allow Company to cultivate, conduct research into, commercialize controlled substances Pure Extracts also announced it recently signed LOI to further cooperation with PURICA(TM)( in field of full-spectrum mushroom-derived wellness products and … Continue reading “Pure Extracts Technologies (CSE: PULL) Signs LOI with PURICA(TM) to Further Research into Mushrooms Wellness Products”

Pure Extracts Technologies Corp. (CSE: PULL) Names Key Advisor; Targets Development of Mushroom Formulations

Pure Extracts is working with Dr. Alexander MacGregor on development of mushroom products, including some combined with CBD. MacGregor is widely renowned as pharmaceutical science inventor, expert in pharmaceutical technology and novel drug-delivery systems. Pure Extracts is focused on expansion of its cannabis extraction business model to include mushroom formulations. Pure Extracts Technologies (CSE: PULL) … Continue reading “Pure Extracts Technologies Corp. (CSE: PULL) Names Key Advisor; Targets Development of Mushroom Formulations”

Pure Extract Technologies (CSE: PULL) Provides Update on Expansion into Functional Mushrooms Sector

Pure Extracts Technologies recently provided update into its expansion into functional mushrooms sector Functional mushrooms have enjoyed surge in popularity as of late, are increasingly being used in wide variety of healthcare, pharmaceutical products Functional mushrooms sector is expected to grow to annual market value of $34.4 billion by 2024 Pure Extracts plans to develop … Continue reading “Pure Extract Technologies (CSE: PULL) Provides Update on Expansion into Functional Mushrooms Sector”

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Begins Facility Build-Out, Prepares to Apply for Dealer’s Licence

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company, has begun build-out work on the fourth unit in is extraction facility; in addition, the company is preparing to submit application to Health Canada requesting a dealer’s licence under the Controlled Drugs and Substances Act (“CDSA”), the government entity that provides the framework for legal access … Continue reading “QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Begins Facility Build-Out, Prepares to Apply for Dealer’s Licence”

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Notes Appreciation for Health Canada Milestone Special Access Programme

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, has voiced its support and appreciation for Health Canada’s recently announced Special Access Programme (“SAP”) for psilocybin-assisted psychotherapy inclusion. The government entity recently announced its intent to revise the SAP and other related regulations to … Continue reading “QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Notes Appreciation for Health Canada Milestone Special Access Programme”

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces Working Collaboration with Leading Pharmaceutical Science Inventor

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company specializing in cannabis, hemp and mushroom products, has announced its partnership with Dr. Alexander MacGregor, a key scientific advisor the company. A renowned expert in pharmaceutical technology and novel drug-delivery systems, MacGregor is a dean of faculty and a distinguished professor of biopharmaceutics and current president … Continue reading “QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces Working Collaboration with Leading Pharmaceutical Science Inventor”

Site Search

Company Search

Search Results for: Cybin